ArticleFrontiers in immunology2024

Integrated immunogenomic analyses of high-grade serous ovarian cancer reveal vulnerability to combination immunotherapy.

Raphael Gronauer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.